NCT07025538 2026-04-20
Biomarker-Guided Ruxolitinib for the Prevention of Chronic Graft Versus Host Disease After Allogeneic Hematopoietic Cell Transplantation
City of Hope Medical Center
Phase 1 Recruiting
City of Hope Medical Center
City of Hope Medical Center
M.D. Anderson Cancer Center
Case Comprehensive Cancer Center
Emory University
H. Lee Moffitt Cancer Center and Research Institute